Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

RCUS

Arcus Biosciences Inc

31.00

Jun 26 • 04:00PM ET +0.75 (2.48%)

Healthcare Biotechnology USA Mid NYSE

Peers: CGON ERAS TNGX KYMR NUVL AXSM BMRN INCY RYTM KRYS

| Held by: IJR XBI VTI IWM VB SPSM VXF IBB XSMO IWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.18	Insider Own	34.05%	Shs Outstand	125.50M	Perf Week	27.52%
Market Cap	3.90B	Forward P/E	-	EPS next Y	-3.44	Insider Trans	-0.19%	Shs Float	82.94M	Perf Month	29.33%
Enterprise Value	3.19B	PEG	-	EPS next Q	-0.89	Inst Own	66.54%	Short Float	16.00%	Perf Quarter	46.16%
Income	-369.00M	P/S	16.52	EPS this Y	-11.81%	Inst Trans	-2.32%	Short Ratio	10.73	Perf Half Y	36.50%
Sales	236.00M	P/B	7.42	EPS next Y	6.39%	ROA	-34.28%	Short Interest	13.27M	Perf YTD	30.09%
Book/sh	4.18	P/C	4.74	EPS next 5Y	11.07%	ROE	-69.95%	52W High	31.44 -1.40%	Perf Year	264.71%
Cash/sh	6.54	P/FCF	-	EPS past 3/5Y	3.94% -7.95%	ROIC	-59.13%	52W Low	7.91 291.91%	Perf 3Y	65.51%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	30.16% 26.08%	Gross Margin	96.19%	Volatility	8.10% 6.63%	Perf 5Y	7.53%
Dividend TTM	-	EV/Sales	13.52	EPS Y/Y TTM	24.05%	Oper. Margin	-168.64%	ATR (14)	1.64	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.04	Sales Y/Y TTM	67.38%	Profit Margin	-156.36%	RSI (14)	74.90	Recom	1.33
Dividend Gr. 3/5Y	- -	Current Ratio	4.04	EPS Q/Q	10.32%	SMA20	22.77%	Beta	0.77	Target Price	36.73
Payout	-	Debt/Eq	0.22	Sales Q/Q	-39.29%	SMA50	24.60%	Rel Volume	3.52	Prev Close	30.25
Employees	601	LT Debt/Eq	0.19	Earnings	May 05 AMC	SMA200	44.93%	Avg Volume	1.24M	Price	31.00
IPO	Mar 15, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	-15.88% -42.34%	Trades		Volume	4,352,623	Change	2.48%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)